318 related articles for article (PubMed ID: 23803409)
1. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
[TBL] [Abstract][Full Text] [Related]
2. A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome.
Mina ED; Jackson KJL; Crawford AJI; Faulks ML; Pathmanandavel K; Acquarola N; O'Sullivan M; Kerre T; Naesens L; Claes K; Goodnow CC; Haerynck F; Kracker S; Meyts I; D'Orsogna LJ; Ma CS; Tangye SG
J Clin Immunol; 2024 Feb; 44(3):66. PubMed ID: 38363477
[TBL] [Abstract][Full Text] [Related]
3. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
[TBL] [Abstract][Full Text] [Related]
4. A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting.
Dirks J; Haase G; Cantaert T; Frey L; Klaas M; Rickert CH; Girschick H; Meffre E; Morbach H
J Clin Immunol; 2022 May; 42(4):771-782. PubMed ID: 35246784
[TBL] [Abstract][Full Text] [Related]
5. A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization.
Yewdell WT; Kim Y; Chowdhury P; Lau CM; Smolkin RM; Belcheva KT; Fernandez KC; Cols M; Yen WF; Vaidyanathan B; Angeletti D; McDermott AB; Yewdell JW; Sun JC; Chaudhuri J
Immunity; 2020 Nov; 53(5):952-970.e11. PubMed ID: 33098766
[TBL] [Abstract][Full Text] [Related]
6. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
Durandy A; Peron S; Taubenheim N; Fischer A
Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N
Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148
[TBL] [Abstract][Full Text] [Related]
9. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.
Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066
[TBL] [Abstract][Full Text] [Related]
10. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.
Xu Z; Pone EJ; Al-Qahtani A; Park SR; Zan H; Casali P
Crit Rev Immunol; 2007; 27(4):367-97. PubMed ID: 18197815
[TBL] [Abstract][Full Text] [Related]
11. A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.
Dahlberg CI; He M; Visnes T; Torres ML; Cortizas EM; Verdun RE; Westerberg LS; Severinson E; Ström L
J Immunol; 2014 Nov; 193(9):4732-8. PubMed ID: 25252954
[TBL] [Abstract][Full Text] [Related]
12. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
Durandy A; Taubenheim N; Peron S; Fischer A
Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
[TBL] [Abstract][Full Text] [Related]
14. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
[TBL] [Abstract][Full Text] [Related]
15. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
Durandy A; Revy P; Imai K; Fischer A
Immunol Rev; 2005 Feb; 203():67-79. PubMed ID: 15661022
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland.
Trotta L; Hautala T; Hämäläinen S; Syrjänen J; Viskari H; Almusa H; Lepisto M; Kaustio M; Porkka K; Palotie A; Seppänen M; Saarela J
Eur J Hum Genet; 2016 Oct; 24(10):1473-8. PubMed ID: 27142677
[TBL] [Abstract][Full Text] [Related]
17. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase.
Zhu Y; Nonoyama S; Morio T; Muramatsu M; Honjo T; Mizutani S
J Med Dent Sci; 2003 Mar; 50(1):41-6. PubMed ID: 12715918
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
19. Autosomal recessive hyper IgM syndrome associated with activation-induced cytidine deaminase gene in three Turkish siblings presented with tuberculosis lymphadenitis - Case report.
Patiroglu T; Akar HH; van der Burg M; Unal E
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):267-74. PubMed ID: 26551569
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of activation-induced cytidine deaminase gene in immunoglobulin-E deficient patients.
Roa S; Isidoro-Garcia M; Davila I; Laffond E; Lorente F; Gonzalez-Sarmiento R
Clin Dev Immunol; 2008; 2008():146715. PubMed ID: 19266080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
